» Articles » PMID: 26798213

Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis

Overview
Journal Korean J Radiol
Specialty Radiology
Date 2016 Jan 23
PMID 26798213
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Sclerosing cholangitis is a spectrum of chronic progressive cholestatic liver disease characterized by inflammation, fibrosis, and stricture of the bile ducts, which can be classified as primary and secondary sclerosing cholangitis. Primary sclerosing cholangitis is a chronic progressive liver disease of unknown cause. On the other hand, secondary sclerosing cholangitis has identifiable causes that include immunoglobulin G4-related sclerosing disease, recurrent pyogenic cholangitis, ischemic cholangitis, acquired immunodeficiency syndrome-related cholangitis, and eosinophilic cholangitis. In this review, we suggest a systemic approach to the differential diagnosis of sclerosing cholangitis based on the clinical and laboratory findings, as well as the typical imaging features on computed tomography and magnetic resonance (MR) imaging with MR cholangiography. Familiarity with various etiologies of sclerosing cholangitis and awareness of their typical clinical and imaging findings are essential for an accurate diagnosis and appropriate management.

Citing Articles

Deep learning radiomics nomogram for preoperatively identifying moderate-to-severe chronic cholangitis in children with pancreaticobiliary maljunction: a multicenter study.

Mao H, Chen K, Zhu B, Guo W, Shi S BMC Med Imaging. 2025; 25(1):40.

PMID: 39910477 PMC: 11800502. DOI: 10.1186/s12880-025-01579-3.


Imaging of Benign Biliary Tract Disease.

Ghuman S, Buxi T, Jain K, Rawat K, Yadav A, Sud S Indian J Radiol Imaging. 2024; 34(4):726-739.

PMID: 39318553 PMC: 11419767. DOI: 10.1055/s-0044-1786038.


Primary sclerosing cholangitis: Is qualitative and quantitative 3 T MR imaging useful for the evaluation of disease severity?.

Boraschi P, Mazzantini V, Donati F, Coco B, Vianello B, Pinna A Eur J Radiol Open. 2024; 13:100595.

PMID: 39206437 PMC: 11357777. DOI: 10.1016/j.ejro.2024.100595.


Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings.

Kim H, Lee S Korean J Radiol. 2023; 24(11):1167-1171.

PMID: 37899526 PMC: 10613835. DOI: 10.3348/kjr.2023.0832.


Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports.

Yacoub H, Ben Azouz S, Hassine H, Debbabi H, Cherif D, Ghayeb F J Med Case Rep. 2023; 17(1):169.

PMID: 37106413 PMC: 10142480. DOI: 10.1186/s13256-023-03908-y.


References
1.
Elsayes K, Oliveira E, Narra V, Abou El Abbass H, Ahmed M, Tongdee R . MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings. J Comput Assist Tomogr. 2006; 30(3):398-404. DOI: 10.1097/00004728-200605000-00009. View

2.
Karlsen T, Franke A, Melum E, Kaser A, Hov J, Balschun T . Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology. 2009; 138(3):1102-11. DOI: 10.1053/j.gastro.2009.11.046. View

3.
Nashed C, Sakpal S, Shusharina V, Chamberlain R . Eosinophilic cholangitis and cholangiopathy: a sheep in wolves clothing. HPB Surg. 2010; 2010:906496. PMC: 2976516. DOI: 10.1155/2010/906496. View

4.
Tsui W, Chan Y, Wong C, Lo Y, Yeung Y, Lee Y . Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features. Semin Liver Dis. 2011; 31(1):33-48. DOI: 10.1055/s-0031-1272833. View

5.
Shimosegawa T, Chari S, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M . International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011; 40(3):352-8. DOI: 10.1097/MPA.0b013e3182142fd2. View